CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Desogus, A.
Right arrow Articles by Fadda, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Desogus, A.
Right arrow Articles by Fadda, G.
Clinical and Diagnostic Laboratory Immunology, July 2003, p. 680-685, Vol. 10, No. 4
1071-412X/03/$08.00+0     DOI: 10.1128/CDLI.10.4.680-685.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Production and Characterization of a Human Recombinant Monoclonal Fab Fragment Specific for Influenza A Viruses

Alessandra Desogus,1,2 Roberto Burioni,3 Angela Ingianni,1 Francesca Bugli,4 Raffaello Pompei,1* and Giovanni Fadda4

Sezione di Microbiologia Applicata, Dipartimento di Scienze e Tecnologie Biomediche, Università di Cagliari,1 Biotecne, Cagliari,2 Istituto di Microbiologia e Scienze Biomediche, Università di Ancona, Ancona,3 Istituto di Microbiologia, Università Cattolica del Sacro Cuore, Rome, Italy4

Received 27 September 2002/ Returned for modification 20 December 2002/ Accepted 25 February 2003

A human recombinant monoclonal Fab fragment that specifically recognizes all the influenza A virus strains tested was produced in transformed Escherichia coli using the phage display technique. No strain of influenza B virus reacted with it. It was purified after four cycles of panning and by a single passage through an immunoaffinity column. About 1 mg of pure monoclonal antibody was obtained from 1 liter of culture medium in 3 working days. The Fab fragment reacted with a viral 27-kDa protein, which could reasonably be a matrix protein. Indirect immunofluorescence tests performed on virus-infected MDCK cells showed that this Fab fragment was at least equally efficient as other commercial monoclonal antibody-based systems in detecting influenza A viral infections. The potential advantages of human recombinant Fabs on murine monoclonal antibodies are discussed.

* Corresponding author. Mailing address: Dep. Scienze e Tecnologie Biomediche, Sez. Microbiologia, Via Porcell 4, 09124 Cagliari, Italy. Phone: 070 675 8483. Fax: 070 675 8482. E-mail: rpompei{at}unica.it.

Clinical and Diagnostic Laboratory Immunology, July 2003, p. 680-685, Vol. 10, No. 4
1071-412X/03/$08.00+0     DOI: 10.1128/CDLI.10.4.680-685.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2003 by the American Society for Microbiology. All rights reserved.